SUMMARY. A case of factitious remission of type I diabetes in an adolescent girl is reported. The clue to diagnosis came from an inconsistency between clinic blood glucose levels and the corresponding values of glycosylated haemoglobin.
Investigations of 24 h hormone and metabolite profiles demonstrated discrepancies between insulin dose. endogenous insulin production and free insulin levels which provided confirmatory evidence of surreptitious self-administration of insulin by the patient.
Most patients who develop type I diabetes enter a phase of partial remission shortly after the start of insulin treatment. I The partial remission or 'honeymoon' period is characterised by an improvement in metabolic control with a concurrent reduction in insulin requirements.': 3 and is associated with significant endogenous insulin secretion. 1- -3 In most patients the recognition of a partial remission presents few problems. but occasional examples of apparent or 'pseudo' remission may occur. Endocrine failure such as hypothyroidism may cause a reduction in insulin requirement" while the appearances of a partial remission may also be simulated by the wilful manipulation of treatment by a patientoften a young girl. 5 The surreptitious selfadministration of insulin is recognised as being a particularly difficult management problem because of the deception of both family and physician which is always involved.I> In monitoring the treatment of diabetes the use of glycosylated haemoglobin (HbA,) has become well-established over the last decade as a method of determining overall glycaemic control. 7 Studies in children with diabetes have confirmed the value of HbA, as an index of glycaemic control in the months following diagnosis.II The near normal blood glucose concentrations that are characteristic of diabetes in partial remission are reflected by correspondingly satisfactory HbA, levels.
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We report a case of factitious remission of diabetes where suspicion was aroused by a discrepancy between serial clinic blood glucose and HbA, values. Confirmatory evidence of manipulation was obtained from in-patient studies of metabolic profiles.
Materials and methods
For each 24 h metabolic profile a cannula was inserted into an antecubital vein and kept patent by flushing with 2 mL saline (154 mmol/L). Free-flowing blood samples were withdrawn at 1800. 1900, 2000. 2100, 2200. 2400. 0300, 0600 h and at hourly intervals thereafter until 1800 h. Main meals were taken after the 1800. 0800 and 1200 h samples and snacks before the 2200, 1100 and 1500 h samples.
At each sample, 2 mL blood was mixed with icc-cold 5'Yo (v/v) perchloric acid and refrigerated immediately. Five millilitres of blood was added to bottles containing lithium heparin. plasma was separated by immediate centrifugation. and insulin antibodies were extracted with an equal volume of 30% polyethylene glycol. The supernatant was stored immediately at -20"C for free insulin assay. The remainder of the plasma was stored at -2(fC for assay of non-esterified fatty acids (NEFA).
ANALYTICAL METHODS Blood glucose. lactate. pyruvate. glycerol, alanine and 3-hydroxybutyrate were assayed in the perchloric extract by continuous-flow enzymatic fluorimetric methods." Acetoacetate was measured within 24 h by a spectrophotometric method. 10 Total ketone bodies refers to the sum of 3-hydroxybutyrate and acetoacetate. Plasma NEFA were assayed using a radiocobalt soap method. II Plasma insulin was measured by a double antibody radio-immunoassay.12 Plasma C-peptide was measured by a commercially available kit (Novo Laboratories Ltd. Copenhagen). HbA I was measured using agargel electrophoresis (Ciba-Corning Diagnostic Ltd. Halstead. Essex. UK). Serum fructosamine was assayed using a commercially available kit (Roche Products. Welwyn Garden City. Herts, UK). Results are expressed as mean±SD. PATIENT The patient. the daughter of a diabetic mother. presented with acute symptoms of diabetes at the age of 14 years. There was no significant past medical history and physical examination was normal. Height and weight both lay between the 10th and 25th centile. Ketonuria was present and the diagnosis of diabetes was confirmed by a blood glucose of 15·5 mmoUL.
She responded well to insulin treatment and was discharged taking Velosulin (highly purified porcine neutral insulin. Nordisk-Wellcome. Epsom. Surrey. UK) 8U with Insulatard (highly purified porcine isophane
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insulin. Nordisk-Wellcome, Epsom. Surrey. UK) 14U in the morning and Velosulin 6U with Insulatard 6U in the evening. This dose was equivalent to 0·75 U/kglday. Subsequent clinic reviews documented satisfactory increases in height and weight along with apparently excellent glycaemic control. The dose of insulin was gradually reduced over the 2 years following diagnosis in response to symptoms suggestive of nocturnal hypoglycaemia. During this time all clinic urinalyses were negative and mid-afternoon capillary blood glucose levels were between 3·0 and 5·0 mmol/L, For the next 6 months. on a dose of 0·12 U/kglday of insulin. she reported occasional symptoms of hypoglycaemia, but remained fit and well and glycosuria was noted on only one clinic visit. This evidence strongly suggested that B-cell function had improved and that the diabetes was in partial remission. The corresponding HbA I levels did not substantiate this presumption (Fig. 1) . In contrast to the consistently low-normal blood glucose levels. HbA I had risen gradually from the beginning of the second year of treatment reaching a peak of 15·5% (reference range 5·{}-8·7%). These unexpected results were clearly inconsistent with the prima-facie evidence of well-controlled diabetes.
Recognised causes of erroneous HbAI results were excluded by appropriate investigations; renal function was normal and no haemoglobinopathy was evident. In addition thyroid function tests were normal as was morning serum cortisol. Serum fructosamine was elevated at 4,11 mmol/L (reference range: 2·0-2,8 mmoVL) supporting the HbA I results.
In an attempt to clarify the situation the patient was admitted overnight to a metabolic ward for the first of two 24 h metabolic profiles.
Insulin was administered by the nursing staff at 1800 h (Insulatard 4U) and 0800 h (Insulatard 2U). The C-peptide levels showed that endogenous insulin secretion was substantially impaired (Table) ; fasting C-peptide was 0·032 nmoVL (reference range for normal adults: 0,154)·52 nmol/L) and 24 h C-peptide was O·04±O,OI nmoVL. Despite the low C-peptide levels and the small amount of exogenous insulin that was prescribed free insulin levels were inappropriately elevated with a 24 h mean of 76·9±41·4 mUlL. Mean 24 h blood glucose was 7·5±4·1 mmoVL and showed considerable lability during the study (Fig. 2) . Subjective symptoms and objective signs of hypoglycaemia were recorded on four occasions during the study. Plasma NEFA and total ketone bodies reached peak levels at the nadir of free insulin concentrations (Fig, 3) . Mean 24 h blood lactate was 1·73±O·65 mmoVL with peak levels of this metabolite coinciding with faIling blood glucose concentrations (not shown).
Before the results of this profile were known by the physician the decision was taken to discontinue insulin completely. The second metabolic profile was performed after a period of 4 weeks during which time the patient admitted to having taken only a single dose of 4U on one occasion. The clinic blood glucose levels during the period allegedly without insulin showed no apparent deterioration in control. but the suspicion of manipulation was heightened by the finding of a random capillary blood glucose of 13·6 mmoVL at a hospital open day. an occasion on which she was not anticipating a blood glucose test.
Although no insulin was prescribed for the second metabolic profile both subjective and objective hypoglycaemia was noted.
C-peptide results were similar to those of the first study (Table) yet the mean free insulin level was even higher at 9O·1±30·4 mUlL. Mean 24 h blood glucose. plasma NEFA and total ketone bodies were all reduced and showed little diurnal variation (Figs 2 and 3) . Mean blood lactate was slightly higher than in the first profile (Table) . Mean blood alanine. glycerol and pyruvate were similar on both occasions (Table) .
Shortly afterwards, still allegedly off insulin. she was readmitted for a further period of inpatient observation. Since the discontinuation of insulin she had continued to experience symptoms suggestive of mild hypoglycaemia. During this admission a bottle of insulin was noticed in her hand baggage by a nurse and the next morning the patient was found to be severely hypoglycaemic with a blood glucose of 1·3 mmoVL.
During an interview later the same day she was questioned about the insulin. At first the existence of the insulin bottle was denied but when confronted with the evidence that strongly favoured factitious hypoglycaemia she admitted to having taken 40U of isophane the night before. She also confessed to taking insulin only before clinic visits for some time and to giving herself exogenous insulin during both metabolic profiles. Underlying personal and family problems were brought to light.
After she had given an explanation of the situation to her parents (who were largely unaware of the amount of deceit involved) she was restabilised on 1·1 U/kglday.
Discussion
The metabolic studies followed from the suspicion that the discrepancy between the low clinic blood glucose levels and high HbA. values might be explained by the administration of doses of insulin prior to clinic visits with indifferent control in-between. That she was able to do this implies some degree of residual insulin secretion allowing her to avoid keto-
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acidosis. Corroborative evidence of manipulation was obtained from the 24 h metabolic profiles. the results of which strongly suggested the administration of substantial additional doses of insulin. The low C-peptide levels and labile metabolite profiles in the first study were clearly inconsistent with a diagnosis of partial remission while the exaggerated free insulin levels with large fluctuations over short periods of time were out of proportion to the prescribed dose of insulin (Fig. 2) . The results of the second metabolic profile suggested that even larger doses of insulin had been taken during the investigation and the higher free insulin levels had effectively suppressed lipolysis and ketogenesis throughout the 24 h period (Fig. 3) . The elevated lactate levels were similar to those found in another study of a group of chronically unstable young type I diabetics. 13 We would be less than honest to imply that the diagnosis was made rapidly preferring to consider the patho-physiological causes of raised glycosylated haemoglobin concentration rather than deliberate deception by the patient. Even when she was apparently taking no exogenous insulin. but experiencing hypoglycaemic symptoms a pathological cause was suggested before the high insulin with low C-peptide results excluded the diagnosis of insulinoma. Others have reported similar reluctance to acknowledge manipulation of diabetes. 14 In cases such as these a time comes when the patient must be confronted about the likely factitious nature of their condition: This is rarely an easy task and firm evidence such as the metabolic data presented may be of additional help in the attempt to uncover the truth.
